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Purpose: The aim of the study was to resolve the genetic etiology in families having inherited cataracts.
Methods: Families afflicted with congenital/childhood cataracts were registered in Chennai and Orissa (India). Blood
samples were collected from the probands and available family members. Selected functional candidate genes were
amplified by polymerase chain reaction (PCR) and characterized by direct sequencing. Putative mutations were confirmed
in healthy controls.
Results: We observed interesting new polymorphisms of ethnic specificity, some of frequent nature, such as a 3-bp deletion
in intron 3 of CRYBB2 (encoding βB2-crystallin) and IVS1+9 c>t variation in HSF4 (encoding heat-shock factor 4). Some
rare single nucleotide polymorphisms (SNPs) co-segregate with the respective phenotype such as IVS3+120c>a of
CRYBB2, while M44V of CRYGD (encoding γD-crystallin), although found in association with blue dot opacity was seen
in a few healthy controls too. We identified two new mutations co-segregating along with the respective cataract phenotype
within the families that were not seen in healthy controls from India or Germany. These include two missense mutations;
one in GJA3 (encoding gap junction protein α3, which is also referred to as connexin 46); the mutation affects codon 19
(T19M), and the corresponding phenotype is a posterior-polar cataract. The other missense mutation affects CRYBB2
(W59C; total cataract). Additionally, a cDNA variation (G54A) identified in a zonular cataract affects a highly conserved
splice site of CRYBB2. This mutation, however, showed reduced penetrance in the family, which might be explained by
different molecular consequences in the affected family members: nonsense-mediated decay of the mutated mRNA might
have no clinical phenotype in heterozygotes, whereas the translation of the mutated mRNA is predicted to lead to a small
hybrid protein (consisting of 16 amino acids of the βB2-crystallin and 18 new amino-acids), which might have a dominant-
negative function in the lens.
Conclusions: This report identifies in families with childhood cataract some new alleles, which may be considered as
causative for cataracts. Furthermore, we report some geographically restricted rare polymorphic sites, whose significance
might be considered in some context as modifiers or alleles in sensitizing ocular lens toward cataractogenesis.
Childhood  cataracts  are  fairly  common,  and  timely
clinical intervention is important for a good visual prognosis.
Globally, about 20 million children suffer from blindness;
over 50% of them indicate a genetic basis, and one third is
familial [1]. In India, cataract accounts for ~12% of childhood
blindness  [2].  When  isolated,  it  exhibits  Mendelian
inheritance  with  autosomal  dominance  as  the  commonest
mode. Molecular analysis revealed ~60 loci to be associated
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with several phenoypes of childhood cataracts (for recent
reviews see [3,4]). Candidate genes include those coding for
αA- and αB-crystallins (CRYAA;CRYAB), for βA1- or βA4-
crystallin  (CRYBA1,CRYBA4),  for  βB1  -  βB3-crystallins
(CRYBB1;CRYBB2;CRYBB3), for γC-, γD-, or γS-crystallins
(CRYGC,CRYGD,CRYGS), for the beaded filament structural
proteins  (BFSP1;BFSP2),  for  connexin  46  (GJA3)  or
connexin 50 (GJA8), for the lens membrane intrinsic protein
2 (LIM2) and for the major intrinsic protein of lens fibers
(MIP).  Another  group  of  candidate  genes  codes  for
transcription factors (heat shock factor 4, HSF4; paired-like
homeodomain transcription factor 3, PITX3; paired-box gene
6, PAX6; eyes-absent 1, EYA1, and for a homolog to the
musculoaponeurotic fibrosarcoma oncogene, MAF). Finally,
also genes encoding enzymes were tested (glucoseaminyl(N-
acetyl)transferase-2,  GCNT2;  chromatin  modifying
protein-4B, CHMP4). Among them, the crystallin-encoding
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1837genes are those having the highest probability to be involved
in  cataract  formation;  however,  some  of  them  are  also
associated  with  other  diseases  besides  cataract  [5].  Other
known  causes  of  congenital,  hereditary  cataracts  are
mutations  affecting  enzymes  of  sugar  metabolism  (e.g.
galactokinase 1, GALK1 [6]) or other metabolic disorders like
hyperferritinemia  (FTL)  [7].  Clinical  as  well  as  genetic
heterogeneity  of  childhood  cataracts  has  been  well
established.  It  is  suggested  that  additional  genes  or
environmental  factors  might  act  as  modifiers  [8].  The
identified genes and their mutations give us some insight into
the process of maintenance of lens transparency and may
increase our understanding of the complexity in age related
cataracts.
The present study is an attempt to screen five families
(CBE21, DJC1, JEE13, JPM1, and SEC18) with autosomal
dominant  congenital  or  childhood  cataract  for  possible
mutations in selected candidate genes like CRYAA; CRYBB2;
CRYGC and CRYGD; GJA3; GJA8,PITX3, and HSF4. We
report the identification of three novel mutations - one in
CRYBB2 (W59C) in a family (JPM1) with total cataract, and
another in GJA3 (T19M) in a family (SEC18) with posterior
polar cataract and the third one with reduced penetrance in
CRYBB2 (G54A) in a proband (DJC1) with zonular cataract.
The  probable  pathogenicity  of  these  mutations  as  disease
causing molecular lesions is discussed in the light of earlier
reports.
METHODS
As part of our ongoing study at the Regional Institute of
Ophthalmology (RIO), Government Eye Hospital, Chennai,
India, several families having visual impairment caused by
hereditary cataracts were registered. One familial case (JPM1)
was  registered  from  the  Rotary  Eye  Hospital  at  Cuttack,
Orissa, India. The probands and their relatives were examined
by senior pediatric ophthalmologists (P.S. and N.G.) with slit-
lamp  microscope  (Zeiss,  Oberkochen,  Germany).  Family
history was recorded according to the information given by
available family members. The study adopted the tenets of the
Declaration of Helsinki, as family members were enlightened
about the study, its outcome and their role in regional language
before seeking informed consent as per standard norms. The
study  was  also  approved  by  the  Institutional  Ethical
Committee of Dr. ALM - Post Graduate Institute of Basic
Medical Sciences, University of Madras, India.
Blood samples (5–10 ml) were collected from available
affected and unaffected family members. Genomic DNA was
isolated  from  peripheral  blood  using  salt  extraction  to
precipitate  contaminating  proteins  as  described  previously
[9]. Genomic DNA was amplified by PCR for the exons (and
their flanking regions) of the CRYAA [10], CRYBB2 [11],
CRYGC,CRYGD  [12],  GJA8,GJA3  [13],  HSF4  [14]),  and
PITX3 (Table 1) genes. PCR products were checked in 1.5%
agarose  gels  and  purified  through  Nucleospin  columns
(Macherey and Nagel, Düren, Germany). Sequencing was
done commercially (GATC Biotech AG, Konstanz, Germany;
or SequiServe, Vaterstetten, Germany) according to standard
procedures.
The mutations were confirmed by the presence/absence
of  the  cleavage  site  for  restriction  enzymes  or  by  direct
sequencing, if no informative restriction site was available.
As controls, 30–100 ethnically matched healthy individuals
were used. Additionally, we took 96 randomly chosen, healthy
individuals  of  the  KORA  Survey  4  (Cooperative  Health
Research  in  the  Region  of  Augsburg,  Germany),  which
studied a population-based sample of 4,261 subjects aged 25–
74 years over the period 1999–2001 [15].
Copy-number variation analysis was done using PCR, the
cloning and counting approach as described previously [16].
Briefly, the following primers were used to amplify the region
around exon 2 of CRYBB2 (UCSC Genome Browser [17]:
human  genome  hg18,  chr22:23,947,149–23,947,711):  5′-
GAC CTC GTT TTT CCC TCC TC-3′ and 5′-GTG GCA
AAA CAG GTA AGG GA-3′. Amplicons were cloned and
around 90 clones per sample were sequenced. Copy number
was determined by calculating the frequency/ratios of alleles
at variations rs16979774, rs7291633, G54A, rs56191632, and
rs739315. Obtained allele ratios were searched for statistical
significant deviations (Fisher’s exact test) from 1:1 which is
the typical situation for two copies per diploid genome (no
copy number variability). A copy number, e.g., of three, would
result in a ratio of 2:1 / 1:2 or frequency of 0.66 / 0.33.
To predict consequences of mutations or polymorphic
sites,  the  Bioinformatics  tool  of  the  ExPASy  proteomics
TABLE 1. PRIMERS FOR AMPLIFICATION OF PITX3 FROM GENOMIC DNA.
Primer Sequence Tm (°C) Size (bp)
PITX3-Ex1-L1 CTGCCATAAAGTGAATGGGCGC 49–60 278
PITX3-Ex1-R1 TCCAAGGTCCAGCAATAGCTCCTC    
PITX3-Ex2-L1 CCATTACCCTGGTCTGTGTCTTCTCTC 56–60 221
PITX3-Ex2-R1 CCCGCACTGGGGATGAAGC    
PITX3-Ex3-L1 TGGGCGCTCTGTGACCTGC 56–60 273
PITX3-Ex3-R1 CGCGGGTGCGAGTCGC    
PITX3-Ex4-L1 CCTTCAGCCGCTGGGACC 63–67 1000
PITX3-Ex4-R1 TCAAGCGCAACTTTGAATCATCAC    
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applied the GOR4 method [18]. To predict splice sites the
NetGene2  World  Wide  Web  Server  from  the  Center  for
Biologic  Sequence  Analysis  was  employed  (Technical
University of Denmark [19]; ). Prediction of regulatory RNA
motifs  was  performed  using  RegRNA,  an  integrated  web
server for identifying the homologs of regulatory RNA motifs
and elements against an input mRNA sequence.
RESULTS
Family CBE21: In family CBE21, the proband was referred
from the Institute of Child Health, Chennai, India, as a case
of  congenital  Rubella  syndrome  to  the  RIO  Egmore  Eye
Hospital, Chennai. The child was 11 months at the time of
case  registration,  had  developmental  delay,  microcephaly,
congenital heart disease, microcornea, nystagmus, and had
dense nuclear opacity with peripheral cortical opacity of the
lens. The child died at the age of 5 years. No DNA sample was
collected from the child. The mother, when examined through
slit lamp, was found to have blue dot opacities. One of the
mother’s sib (II.6) at the age of 12 years is said to have
undergone surgery for cataract. Follow up visit of this family
revealed the family to have a second child who is said to be
healthy. The pedigree of this family is given in Figure 1, and
the case history of the family in Table 2.
Molecular genetics of Family CBE21: The mother’s genomic
DNA was screened for all exons and their flanking sequences
of  some  functional  candidate  genes  (CRYAA,  CRYGC,
CRYGD,  and  PITX3).  This  functional  candidate  gene
approach  detected  a  mutation  in  exon  2  of  CRYGD.
Comparison  of  the  wild-type  sequence  with  that  of  the
proband’s  mother  demonstrated  a  heterozygous  C→T
mutation at position 130 (C130T; Figure 2A), which leads to
an amino acid exchange from Met to Val at pos. 44 (M44V;
Figure  2B).  Further,  the  mutation  creates  a  new  Alw21I
restriction site (Figure 2B). Restriction digest showed co-
segregation  of  the  genotype  with  only  one  other  affected
member of the family (Figure 2C; III.6). The third affected
member was PGM (II.2; 60 years), who also had blue dot
opacities, but the restriction site for Alw21l was absent. This
restriction site is absent in the proband’s father (III.3) and in
unaffected relatives of other cataract probands (n=5; data not
shown), it was also not detected in 60 healthy controls from
the general population of India but was observed in 6 of the
96 healthy controls (KORA) from Germany. Therefore, it
could not be considered as a causative mutation, but may be
interpreted as a polymorphism with an allele frequency of
6.2% in the German population.
Family JEE13: The proband, a female child of 6 years (as on
2005)  of  family  JEE13  had  a  triangular  central  cataract
surrounded by cataractous dots and fibers in the lens cortex
(Figure 3A). The other eye (LE) was operated earlier on. The
proband’s mother (23 years) was examined to have lamellar
with peripheral coronary cataract at both eyes and her visual
acuity being 3/60. The eyes of the proband’s sib (3 years)
however  are  healthy.  One  of  the  mother’s  sibs  was  also
affected  who  has  three  healthy  children  (not  clinically
examined).  The  pedigree  (Figure  3B)  demonstrated  an
autosomal  dominant  mode  of  inheritance  as  the  cataract
appeared in all three generations affecting both sexes.
Molecular genetics of Family JEE13: Molecular analysis of
some  functional  candidate  genes  like  CRYAA,  CRYBB2,
Figure 1. Cataract phenotype in family CBE21. Pedigree of the
family CBE21 indicates consanguinity after one generation. The blue
dot  opacity  appeared  in  the  second  generation  and  affects  four
members of the family. The deceased proband (IV-7) is indicated by
an arrow. The numbers below the symbol indicate the laboratory
number of the samples.
TABLE 2. CASE HISTORY OF FAMILY CBE21.
Subject code Relationship Age (Years) VA (L/R) VA (L/R) SLE
II.2 Proband’s
grandmother
55 6/60;6/60 6/6;6/9 Fine blue dot cataract opacity
III.5 Proband’s elder uncle 21 6/60;6/60 6/6;6/9 Fine scattered blue dot opacities
III.6 Proband’s younger
uncle
17 6/6;- -;- Fine blue dot opacities minimal and
scattered
        The proband IV.7 was deceased at the age of 5 years. Subject III.6 was operated on at the age of 13 years for removal of a
        traumatic cataract in his right eye due to a stick injury at the age of 5 years.
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1839CRYGC, CRYGD, GJA3, GJA8, HSF4, and PITX3 revealed a
C→T mutation at the beginning of intron 1 of HSF4 (position
#9; Figure 4A); this heterozygous mutation was also present
in the affected mother. The mutation leads to a loss of a HaeIII
restriction site (Figure 4B) and segregates perfectly in the
family (Figure 4C), and was not detected in 96 unrelated
controls of the German population. However, among the 35
unrelated and healthy controls from India, 6 of them showed
the  same  restriction  pattern  as  observed  in  the  cataract
patients. Therefore, this SNP might be specific for the Indian
ethnicity  (~17%),  and  is  not  associated  with  cataract
formation. This inference is further being supported by the
fact  that  the  mutation  occurs  outside  of  the  conserved
Figure  2.  CRYGD  mutation  in  the  family  CBE21.  A:  Sequence
analysis of exon 2 of CRYGD indicates heterozygosity (arrow) for
the mother of the proband (III.4). B: Comparison of the wild-type
sequence  (WT)  with  the  proband’s  mother’s  sequence  (CBE21)
demonstrates that the C→T mutation at cDNA position 130 leads to
an  amino  acid  exchange  from  Met  to  Val  at  pos.  44  (M44V);
moreover, it shows the creation of a new Alw21I restriction site
(underlined) in two (III.4 and III.6) of the affected members of the
family checked, while the same was absent in the proband’s grand
mother (II.2). One of the proband’s uncle (III.5) could not be checked
(in the cDNA sequence, the A of the ATG start codon is counted as
#1; in the amino-acid sequence, the first Met is counted as #1). C:
Restriction analysis with (+) or without (-) the enzyme Alw21I in the
members of the core family leads to an additional fragment of 370
bp in the mutant DNA (red); it demonstrates the presence of the
mutation in the affected mother (III.4) and the affected brother of the
proband’s mother (III.6). The asterisks mark the additional band of
370 bp indicating the mutation; the band of 533 bp indicates the
undigested DNA. WT represents an independent control from the
laboratory; M=marker.
recognition sites for splicing; several splice site prediction
programs failed to show any influence on splicing.
Family DJC1: The pedigree of the large family DJC1 is shown
in Figure 5A. The phenotype “congenital zonular cataract”
seems to appear spontaneously in the youngest daughter as
proband (1.5 years as on 2005) whose visual acuity (by ivory
ball testing) was found to be >6/60 at a distance of 0.5–1.0 m.
Both eyes of the proband were operated on, with no other
systemic involvement. Her parents were related as first degree
cousins.  Both  the  parents  and  her  three  sibs  underwent
complete ophthalmologic check-up and were declared to have
regular vision.
Molecular genetics of Family DJC1: Molecular analysis of
functional  candidate  genes  CRYAA,  CRYBB2,  CRYGC,
CRGYD, GJA8, and PITX3 revealed a single heterozygous
base-pair exchange at the last base of exon 2 of the CRYBB2
gene (cDNA-G54A; Figure 5B). The mutation does not affect
the amino acid in the corresponding codon 18 (it remains Leu;
Figure 5C), however, the A instead of the G destroys the
common  donor  splice  site,  and  a  splice-site  prediction
program  suggests  that  the  corresponding  splice  site  is
completely lost. The most likely next donor splice site might
be 338 bp downstream (calculated probability is 79%). If this
would be true, the corresponding intronic sequences will be
Figure 3. Cataract phenotype in family JEE13. A: A lamellar cataract
was observed in the 6-year-old proband. B: The pedigree of a 3-
generation family demonstrates that the cataract appeared in all three
generations affecting both sexes; it indicates an autosomal dominant
mode of inheritance. The proband is indicated by an arrow.
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1840present in the mRNA and translated resulting in 16 novel
amino  acids;  translation  will  then  be  terminated  by  a
premature stop codon.
As the mutation leads to a loss of an Eco130I restriction
site, its presence or absence was then tested in the core family
(father II.5, mother II.6, and the siblings III.1–3) as well as in
controls of German origin (n=96) and from unrelated controls
of  India  (n=35).  We  did  not  observe  the  mutation  in  the
German controls, also it was absent in controls from India.
Surprisingly, the healthy mother (II.6) and one of the healthy
sisters  (III.3)  showed  the  same  digestion  pattern  as  the
proband. Therefore, we sequenced also the corresponding
CRYBB2 exon in the parents (II.5 and II.6) and siblings (III.
1–3) of the proband. The mother and the sister III.3 had a
small,  but  significant  fluorescence  A  peak  suggestive  for
copy-number  variability  of  the  locus.  Therefore,  we
quantified the allele frequencies of the cDNA-G54A mutation
and surrounding SNPs, but the result indicated a 1:1 ratio of
the respective alleles typical for a heterozygous single-copy
Figure 4. HSF4 mutation in family JEE13. A: Sequence analysis of
HSF4 genomic DNA indicates heterozygosity at position +9 of the
first intron (red arrow) of the proband’s HSF4 gene. B: Comparison
of the wild-type sequence (AB029347) with the proband’s sequence
demonstrates a C→T exchange at position 9 of intron 1. The mutation
leads to a loss of a HaeIII restriction site (underlined). C: Restriction
analysis with (+) or without (-) the enzyme HaeIII in members of the
family leads to an additional fragment of 98 bp in the mutant DNA
(red); it demonstrates the presence of the mutation in the affected
mother (II.3) and in the proband (III.4). The asterisks mark the
additional band of 98 bp indicating the mutation; the band of 262 bp
indicates the undigested DNA. C40 and WT represent independent
controls from our laboratories; M=marker.
locus. Therefore, this mutation has to be evidently described
as having reduced penetrance. Since no operated lens material
is available it remains speculative whether the 34-amino acid
peptide is actually present in the cataractous lenses or if the
mutated mRNA is subjected to nonsense-mediated decay in
the clinically healthy family members.
Family JPM1: The proband, a female child of age 2.5 years
at the time of registration, was diagnosed to have bilateral
Figure 5. CRYBB2 mutation in family DJC1. A: The pedigree of
family  DJC1  indicates  that  a  zonular  cataract  appeared  in  the
youngest daughter of healthy, but consanguineous parents. There is
no other report of any type of cataract over three generations. B:
Sequence  analysis  of  CRYBB2  genomic  DNA  indicates
heterozygosity for the proband at cDNA pos. 54 (red arrow). C:
Comparison of the wild-type sequence (Z99916) with the proband’s
sequence demonstrates that the G→A exchange at cDNA-position
54 leads to an altered splice site; it is predicted that the mutated
mRNA contains at least part of intron 2 (the A of the ATG start codon
is counted as #1; in the amino-acid sequence, the first Met is counted
as #1). The mutation leads to a loss of an Eco130I restriction site.
D: Restriction analysis using the enzyme Eco130I creates a larger
fragment of 216 bp in the mutant DNA (red); it demonstrates the
presence of the mutation in the proband (III.4), but surprisingly also
in the healthy mother (II.6) and one healthy sister (III.3) of the
proband; the asterisks mark the additional band of 216 bp indicating
the mutation. Undigested PCR fragments of 393 bp are indicated by
“-” or “+” are digested PCR products. The small fragment of 51 bp
in the wild-type DNA is not visible; the two bands of 165 and 177 in
the wild type are not separated under the conditions used here. C1
and  C2  represent  independent  controls  from  the  laboratory;
M=marker.
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1841congenital cataract (Figure 6A) along with amblyopia and
nystagmus in the left eye. There was no other associated ocular
or systemic anomaly. She was operated for removal of total
cataract in both eyes by lens aspiration, primary posterior
capsulotomy  and  anterior  vitrectomy.  The  mother  had  no
history  of  any  systemic  ailments  during  pregnancy.  The
child’s developmental milestones were reported to be normal.
The child was affected since birth. The father and a male sib
were  also  affected;  three  of  father‘s  sibs  were  said  to  be
affected with cataract. The entire pedigree is shown in Figure
6B.
Molecular genetics of Family JPM1: Molecular analysis of
some  functional  candidate  genes  like  CRYAA,  CRYBB2,
CRYGC,  CRYGD,  GJA8,  and  PITX3  revealed  a  G→C
mutation at the beginning of exon 4 of CRYBB2 at position
177 leading to an exchange of Trp by Cys (W59C; Figure 7A);
the mutation is predicted not to affect the formation of 2nd
Greek  key  motif.  Rough  computer-assisted  prediction  of
biophysical properties suggests that the hydrophobicity of the
area  around  W59  slightly  increases  (from  1.4  up  to  1.7);
although the isoelectric point of the protein is not altered. The
mutation destroys a BseY1 restriction site (Figure 7B) which
is seen only in affected family members (Figure 7C); it is not
present  in  unrelated  controls  from  India  (n=100)  or  from
Germany (n=96). Therefore, this mutation is most likely to be
the causative genetic lesion for the cataract in this particular
family.
Family SEC18: The proband (III.2) is a male child of 9 years
at  the  time  of  case  registration  at  RIO  in  2007,  with  a
complaint  of  posterior  polar  cataract  in  his  left  and  was
Figure 6. Cataract phenotype in family JPM1. A: The eye picture
shows a central opacity of both lenses of the female proband (III.2;
2.5 years). B: The central lens opacity appeared in 4 out of 7 siblings
of seemingly healthy parents (generation I); one of the brothers
(generation  II)  transmitted  the  cataract  to  both  his  offspring
(generation  III)  indicating  an  autosomal  dominant  mode  of
inheritance. The mutation might have originated in the germ cells of
the healthy grandparents (generation I).
pseudoaphakic in his right eye. He underwent cataract surgery
at the age of 4y. Presently, his visual acuity is 6/12p with PH
6/12. Subsequently, he had Yag capsulotomy done on his left
eye at the age of 9 years (Figure 8A). His elder brother (III.1)
is also affected. The pedigree (Figure 8B) demonstrates that
the cataract developed spontaneously in the father (II.2) who
was operated earlier at the age of 22 years for his right eye.
He was 25 years old at the time of his second surgery at left
eye for removal of posterior polar cataract. His visual acuity
was 6/36 with PH 6/18 at left eye. His pupil is said to be
irregular with no other ocular anomalies. Fundus examination
revealed his retina with no pathological findings.
Molecular genetics of family SEC18: Molecular analysis of
some functional candidate genes (CRYAA, CRYGC, CRYGD,
GJA3,  GJA8,  and  PITX3)  revealed  a  C→T  mutation  of
GJA3 (cDNA position # 56; Figure 9A,B); at the amino-acid
level, it exchanges the Thr at codon 19 by a Met (T19M). The
mutation forms a new restriction site for NcoI. The mutation
segregated within the family (Figure 9C) among the affected
Figure 7. CRYBB2 mutation in family JPM1. A: Sequence analysis
of CRYBB2 genomic DNA indicates heterozygosity in the proband’s
father (II.7) at cDNA pos. 177 (red arrow). B: Comparison of the
wild-type sequence (Z99916) with the proband’s father sequence
demonstrates that the G→C exchange at cDNA-position 177 leads
to an exchange of Trp by Cys (W59C). The BseY1 restriction site in
the wild-type sequence is underlined. C: Restriction analysis using
the enzyme BseYI leads to an additional fragment of 137 bp in the
mutant DNA (red); it demonstrates the presence of the mutation in
the  affected  father  (II.7)  and  the  affected  brother  (III.1)  of  the
proband (III.2). The asterisks mark the additional band of 137 bp
indicating the mutation; “undig” is an undigested PCR fragment of
239 bp. WT represents an independent control from the laboratory;
M=marker.
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controls of either Indian (n=100) or German origin (n=96).
The mutation affects the last amino acid of the NH2-
terminal cytoplasmic domain and is predicted not to alter the
first transmembrane domain. However, secondary structure
prediction  program  (GOR4)  suggested  that  the  extended-
strand and random-coil structure between amino acids 17 and
26 was then changed to an α-helical structure, which runs in
the mutant protein from amino acid 5 to 24. It enhances the
fraction of the α-helical structure from 42.5% in the wild-type
protein to 44.6% in the mutant connexin46.
DISCUSSION
Here we report a screen of five families with members having
congenital  or  childhood  cataracts  (CBE21,  DJC1,  JEE13,
JPM1, and SEC18). We identified three mutations being most
likely causative for congenital or childhood cataracts in these
families from India – one affects the GJA3 gene encoding
connexin  46,  the  other  two  affect  CRYBB2  encoding  β-
crystallin. As the size of the families was rather small we
resorted to apply a functional candidate gene approach.
While investigating, two new rare polymorphic sites were
documented  in  some  of  the  candidate  genes.  The
nonsynonymous  change  M44V  in  the  CRYGD  gene  was
identified  in  two  (of  four)  affected  members  of  a  family
(CBE21) who suffer from blue dot opacities. This variation
was not observed in 60 of the unrelated population controls
from India while the same was observed in ~6% of the German
controls. In family JEE13, the SNP, IVS1+9 c>t in HSF4 was
observed  rather  frequently  (~17%)  in  controls  of  Indian
Figure 8. Cataract phenotype in family SEC18. A: The posterior polar
cataract in the proband (9 years) is demonstrated in the left eye; the
right eye is pseudoaphakic. B: Pedigree of family SEC18 indicates
the  occurrence  of  the  cataract  in  the  second  generation  of  two
unrelated families; it is fully transmitted to both sons in the third
generation.
origin.  These  results  suggest  ethnic  specificity  of  certain
polymorphisms;  since  these  SNPs  do  not  explain  the
Mendelian type of inheritance, they might act as susceptibility
alleles  for  cataracts  in  the  respective  populations.  In  our
screening, several common SNPs were also documented in
some of the candidate genes (Table 3) representing coding as
well as non-coding regions. SNPs in non-coding regions may
influence promoter activity, splicing (in introns), translational
efficiency (by different codon usage) or mRNA stability (in
3′-UTR). Therefore, it is evident that SNPs may alter gene
function and lead to phenotypic modifications.
In the present study, two new mutations in CRYBB2 have
been  identified.  In  family  DJC1;  a  splice-site  prediction
program suggests that the G54A mutation of CRYBB2 disrupts
the conserved donor splice site. Unfortunately, this could not
be validated further, because experiments on splicing aspects
need surgical lens exudates from the proband. This mutation
was not observed in the general population of neither Indian
(n=35) nor of German (n=96) origin, but it showed reduced
penetrance in the family, since two members (the mother and
one sister) carry the mutation without clinical findings. Given
this ambiguity, it would be interesting to have an animal
model for this particular mutation to further understand its
mode of action: If the splice site is destroyed, a premature stop
Figure 9. GJA3 mutation in family SEC18. A: Sequence analysis of
GJA3 genomic DNA indicates heterozygosity (red arrow) in the
proband.  B:  Comparison  of  the  wild-type  sequence  with  the
proband’s sequence demonstrates a C→T exchange at position 56
leading  to  an  amino  acid  alteration  at  codon  19  (T19M).  C:
Restriction analysis with (+) or without (-) the enzyme NcoI in
members of the family leads to an additional fragment of 688 bp in
the mutant DNA (red); it demonstrates the presence of the mutation
in the affected father (II.2), in the proband (III.2) and in his brother
(III.1). The asterisks mark the additional band of 688 bp indicating
the mutation; the band of 732 bp indicates the undigested DNA. WT
represents independent control from the laboratory; M=marker.
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1843codon is present after 16 codons resulting in a short peptide
of 34 amino acids. If this peptide is formed, a dominant-
negative phenotype might be expected; in case of nonsense-
mediated decay of the mutated mRNA, a loss-of-function
phenotype without clinical relevance in heterozygotes might
be expected. Individual variations among the affected family
members  might  explain  the  observed  reduced  penetrance,
since the corresponding Crybb2 knockout mutation in the
mouse indicates a less severe phenotype in the homozygotes
as compared to the heterozygous dominant point-mutations
[20] (the phenotype of heterozygous knockout mutants is not
reported and might be considered to be indistinguishable from
the wild type).
The second novel mutation, W59C in CRYBB2, has been
identified to segregate in all affected members of the JPM1
family afflicted with total cataract; no other systemic ailments
were obvious. Human βB2-crystallin, has five Trp residues,
of which three are in the 2nd Greek key motif at amino acid
positions (59, 81, and 84), one in the 4th Greek key motif
(151), and the last one in the COOH-terminal extension (194).
At position 59, Trp (single letter code W) seems to be a buried
residue  conserved  both  in  acidic  as  well  as  in  basic  β-
crystallins  [21]  depicting  phylogenetic  significance.  The
sequence variation W59C disrupts the conserved Trp residue
by substitution of Cys. In human βB2-crystallin, two Cys
residues are located at amino acid positions 48 (1st Greek key
motif) and 67 (2nd Greek key motif). The putative mutation
W59C introduces a third Cys residue in the mutant βB2-
crystallin. Theoretically, this might increase the scope for
more Cys-mediated crosslinks through di-sulphide bridges
which might disrupt the folding and change the topography of
the  amino  acids  in  the  vicinity.  As  per  an  earlier  report,
formation of a disulphide bond involving Cys-37 and Cys-67
of  βB2-crystallin  has  been  observed  in  a  human  nuclear
cataract [22]. Moreover, the microenvironment surrounding
the W59 might change in consequence to the mutation, but
this hypothesis needs to be verified by appropriate biophysical
methods. Interestingly, both the variations W59C (JPM1) and
IVS2+1g>a (DJC1) are also in association with an SNP viz.,
IVS3+120c>a (71307c>a) as was observed earlier in a central
nuclear cataract with the mutation W151C of βB2-crystallin
[11]. This SNP could therefore act as a molecular tag denoting
a marker/modifier for putative mutations in CRYBB2. Putting
together the above points, the mutation W59C could well be
considered as the molecular lesion for the dominant cataract
in the family JPM1.
The appropriate association of β-crystallins into higher-
order  complexes  is  critical  to  the  maintenance  of  lens
transparency and a high refractive index [23]. Besides the lens,
β-crystallins are expressed in other tissues such as retina,
brain, and testis [24,25] implying its role in other biologic
functions as well, like elongation of axons during regeneration
of retinal ganglion cells [26].
Mutations in human CRYBB2 have been reported to be
associated with variable dominant cataract phenotypes [5,8]
like  Cerulean  cataract  [27],  Coppock-like  cataract  [28],
Cerulean and sutural cataract [29], a variable phenotype in a
Chinese  family  [30],  a  dominant  congenital  cataract  in  a
Chilean family [31], and progressive polymorphic congenital
coronary  cataract  [32].  The  mutation  Q155X  depicted  a
decrease in protein–protein interaction and decreased ordered
structure  and  stability.  However,  the  partially  unfolded
protein was found to retain some dimer structure [33]. It is
understandable that such heterogeneity in dominant cataracts
may  be  attributed  either  to  ethnic  background,  or
environmental or other modifiers.
Moreover, three other mutations have been identified in
CRYBB2: W151C in a dominant central nuclear cataract [11]
in an Indian family, D128V, affecting exon 5 of the human
CRYBB2 gene in a German family depicting nuclear cataract
with an additional ring like cortical opacity [34], and third the
TABLE 3. SNPS DOCUMENTED IN CATARACT PROBANDS/AFFECTED RELATIVES OF INDIAN ORIGIN.
Genes Non coding Family code Coding Family code
CRYAA IVS2+27 g>c CBE21;DJC1 rs60485881 CBE21
CRYBB2 65843t>a;(IVS1+31t>a) JEE13 54 g>a; K18K DJC1
  65894a>g;(IVS1+84a>g) JEE13 rs17842553 SEC18
  71307c>a;IVS3+120c>a) DJC1; JPM1    
  73644a>g;(IVS3–360a>g) JEE13;DJC1    
  75738 g>a;(IVS5+9g>a) JEE13;DJC1 77788 g>a;G161G JEE13;DJC1
CRYGC none none rs3189020 Sec18
CRYGD 517t>c; IVS2+30t>c CBE21;DJC1;JPM1; 286t>c; Y16Y JPM1;DJC1;
    JEE13 365a>g;M43V CBE21
  570c>t; IVS2+83t>c CBE21;DJC1;JPM1; 285a>g;R94R CBE21
    JEE13   JEE13
  553c>t-3′UTR JEE13    
GJA3 rs968566 SEC18 none none
GJA8 none none none none
PITX3 none none rs17858134 SEC18;CBE21
HSF4 IVS1+9 c>t JEE13 none none
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1844mutation  S31W  co-segregated  in  a  Chinese  family  with
inherited coronary cataract [35].
In mice, three mutant lines have been reported to affect
βB2–crystallins, the Philly mouse, AEY2, and O377. In the
Philly mouse, the progressive opacity involves the nucleus
and the anterior sutures [36], while in Aey2 a progressive
opacification of the whole lens sets in by the age of 11 weeks
[37], and in O377 the phenotype is a progressive cataract with
a small lens [25]. Further studies of Crybb2 mutations in
animal models might throw light on potential regions of β-
crystallin molecule trivial for protein association.
Connexins-46  and  −50  are  important  for  proper  lens
development  and  differentiation  of  their  fiber  cells;  they
enable contact not only to the anterior epithelial cells, but also
among  the  lens  fiber  cells  [38-42].  Several  mutations
documented in GJA3 and GJA8 substantiate this statement
[8]. Here we report a new mutation as T19M in GJA3, which
was observed in a 9-year-old proband having a posterior polar
cataract; the same phenotype and the same mutation (T19M)
was confirmed in his elder brother and father, but it was not
observed in any of his unaffected family members checked
(SEC18). The putative mutation T19M occurs at a highly
conserved site both across the family of connexins as well as
across species. As per secondary structure prediction program
(GOR4), it enhances the fraction of the α-helical structure in
the mutant connexin-46.
Altered function and/or expression of specific connexin-
encoding  genes  have  been  linked  to  several  diseases,
including  genetic  deafness,  skin  disease,  peripheral
neuropathies,  and  cataracts  [39].  The  cataract-causing
mutations in GJA3 include Asp3Tyr [43], Leu11Ser [44],
Val28Met [45], Phe32Leu [46], Arg33Leu [47], Pro59Leu
[48],  Asn63Ser  [49],  Arg76Gly  [45],  Thr87Met  [50],
Pro187Leu [51], Asn188Thr [52], and c.1137insC causing a
frameshift at codon 380 [49]. It is obvious from this list that
most  mutations  identified  in  human  autosomal  dominant
congenital cataracts (ADCC) so far affect the first half of the
protein  and  the  majority  of  murine  cataracts  occur  in  E1
domain [4]. Except the COOH-terminal frame-shift mutation
viz., S380fs, all others are missense mutations spread over the
NH2-terminus (2nos.), M1 (3nos), E1 (3nos.), at boundary of
E1/M2  (2nos.),  M2  (1no)  and  at  E2  domains  (2nos)  of
Connexin-46. In human, most mutations seem to be associated
with  zonular  pulverulent  opacities  featuring  nuclear  or
perinuclear regions. However, other variable phenotypes such
as anterior capsular with cortical opacities [45], nuclear [53]
and  total  cataracts  [45]  have  also  been  encountered.
Interestingly, the mutation T19M in the present study and the
one  in  an  earlier  report  (T87M)  are  missense  mutations
substituting a polar amino acid (Thr) for a non-polar one
(Met); they are phenotypically different in a way that might
reflect their domain location.
In  rats,  a  non-conservative  missense  mutation  was
reported (Glu42Lys [54]), and a knockout mutation of Gja3−/
− in mouse causes nuclear opacity [55]. Gja3 knock outs in
mice  present  various  degrees  of  cataractous  opacity
depending on the genetic background [40] as was also seen
with the intra familial variation in the Chinese family. Murine
Gja8 dominant as well as null mutations also display different
types of cataracts [56,57]. On the contrary to the mutations
mapped in Gja8, all missense mutations in Gja3 are dominant
as discussed earlier [13]. Therefore, it is well documented that
genetic background does influence the severity of cataract
phenotypes  with  connexin  mutations  [58].  Moreover,
electrophysiological studies of the Gja8-G22R mutation at the
NH2-terminal  region  have  confirmed  that  mutant  subunits
alter the gating and conductance of gap junction channels in
vitro  [59].  Similar  experiments  on  the  new  T19M  GJA3
mutant  protein  might  help  to  understand  the  biophysical
properties of the mutant connexin-46 molecule in conjunction
with the wild type protein.
In conclusion, we present here ample evidence for new
cataract-causing mutations in CRYBB2 and in GJA3. The data
presented  focuses  on  the  complexity  of  genetic  and
phenotypic diversity of congenital or childhood cataracts in
humans.
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